STING agonist (ViiV Healthcare/Emory University School of Medicine/University of North Carolina)

N/A

Report date: 2025/03/20 09:25:20
NME

Base Information

Drug NameSTING agonist (ViiV Healthcare/Emory University School of Medicine/University of North Carolina)
Drug Alias NameSTING agonist (ViiV Healthcare/Emory University/UNC)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStimulator of interferon genes stimulants
TargetsStimulator of interferon genes
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesViiv Healthcare Ltd
China Registration ClassN/A

Develop Information

Active CompaniesViiv Healthcare LtdUniversity Of North Carolina, GreensboroEmory University
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A